Latest filing published 30 Jun 2025 for Roquefort Therapeutics plc, €1,166.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Simon Sinclair: trading record in brief
This profile gathers the share dealings of Simon Sinclair in Roquefort Therapeutics plc. Over a trading history stretching from 27 September 2022 to 27 June 2025, the count stands at 3 filings.
Every open-market trade on record is a purchase: 3 purchases worth €9,654, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €2,900. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 30 June 2025 came the latest disclosure, an open-market purchase for €1,166 in Roquefort Therapeutics plc. Filings reach the RNS (LSE) feed a median of 1 day after the trade. The legal deadline for notifying a trade is three business days (UK MAR). These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Simon Sinclair
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 72,507 shares@ £0.013728.7% of flowLondon Stock Exchange (XLON); Main MarketISIN GB00BMDQ2T15RNS:5715997Canonical exit: 25 Sept 2025 (T+90)
- 35,921 shares@ £0.069371.3% of flowLondon Stock Exchange (XLON); Main MarketISIN GB00BMDQ2T15RNS:4814686Canonical exit: 24 Sept 2023 (T+90)
- 60,415 shares@ £0.082857.9% of flowLondon Stock Exchange (XLON); Main MarketISIN GB00BMDQ2T15FCA-NSM:4524276-1Canonical exit: 26 Dec 2022 (T+90)
3 of 3 declarations